Reaction
X-Linked Lymphoproliferative Syndrome reporting signals
As of the last recalculation, X-Linked Lymphoproliferative Syndrome appears in 33 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is CANAKINUMAB (PRR 5,127.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Canakinumab | 24 | 5,127.5 | 5,139.0 |
| Colchicine | 24 | 2,104.8 | 2,106.8 |